Blackfield AG is leveraging the genome analysis experience and oncology expertise of its academic founders to offer a one-stop shop for cancer genomics-based drug discovery services.

The University of Cologne spinout was founded last year to commercialize work from the lab of Roman Thomas, chair of the department of translational genomics and Blackfield's scientific director.